ClinicalTrials.gg
RecruitingNCT07029984Updated Feb 17, 2026

Baylor Continence Scale Validity in Anorectal Malformation

An observational study in Anorectal Malformations, sponsored by Izmir Bakircay University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 6 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-02-17.

Sponsored by Izmir Bakircay University · Observational

From the registry’s dates

  • Primary completion was expected by May 2026, 6 months ago, but the record still lists the study as recruiting.
  • Started May 2025; still recruiting 1 year 6 months later.
Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
230
Ages
6 Years to 18 Years
Sex
All
01

Study summary

The aim of this study is to evaluate the validity and reliability of the Baylor Continence Scale in Turkish-speaking children diagnosed with anorectal malformations. The scale is used to assess continence levels, helping healthcare providers make informed decisions regarding treatment and follow-up. The study includes a sample of children with confirmed anorectal malformations, and data collection consists of language adaptation, statistical validation, and reliability testing. Results will contribute to the standardization of continence assessment in Turkish clinical settings, ensuring accurate evaluations for pediatric patients.

02

Conditions studied

  • Anorectal Malformations

Keywords

  • Anorectal Malformation
  • Baylor Continence Scale
  • Validity and Reliability
03

In context

Anorectal Malformations

30 studies on the registry are indexed under Anorectal Malformations; 10 are open to participants now.

This study's planned enrollment of 230 is above the median of 190 across 18 observational studies indexed under Anorectal Malformations.

Browse Anorectal Malformations studies →

Lead sponsor

Izmir Bakircay University is the lead sponsor of 75 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Inclusion criteria for the study include children who have undergone surgery due to anorectal malformation, are between 6 and 18 years old. Exclusion criteria consist of cases where the child and caregiver have comprehension, hearing, or vision problems that could affect communication or participation in the study.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Having undergone surgery due to anorectal malformation
  • Being between 6 and 18 years old
  • The child and caregiver are required to know Turkish

Exclusion criteria

Exclusion Criteria:

  • The child and caregiver having comprehension, hearing, or vision problems
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
230 participants (estimated)
Patient registry
No

Groups and cohorts

  • Children with Anorectal Malformations

    Having undergone surgery due to anorectal malformations, Being between 6 and 18 years of age, The child and caregiver knowing Turkish

    Other: Baylor Continence Scale

Interventions

  • OtherBaylor Continence Scale

    This study may be one of the first to test the Turkish adaptation and validity of the scale in Turkish children with anorectal malformations.

06

What researchers measure

Primary outcomes

  1. Validity and Reliability Analyses

    In this study, validity and reliability analyses will be conducted as part of the Turkish adaptation of the Baylor Continence Scale.

    Time frame: Average 6 to 12 month

07

Study locations

1 of 1 sites recruiting
  • Ege University Department of Pediatric Surgery and Bakırçay University Physical Therapy and Rehabilitation Application and Research Center
    Izmir, Turkey (Türkiye)
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07029984
Lead sponsor
Izmir Bakircay University
Collaborators
Ege University
Responsible party
AYŞE KAYALI VATANSEVER (Assistant Professor, PhD, Izmir Bakircay University) — Principal investigator
First posted
Jun 19, 2025
Start date
May 10, 2025
Primary completion
May 2026 (estimated)
Completion
Jun 2026 (estimated)
Last update
Feb 17, 2026

Study contacts

Ayşe Kayalı Vatansever, Assistant Professor, PhD
Contact
ayse.vatansever@bakircay.edu.tr
+905529382360

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion